People: HHS Secretary Appoints New Deputy Director At NIH Institute

Marvin Cassman has been appointed deputy director, National Institute of General Medical Sciences, by Health and Human Services Secretary Louis W. Sullivan. Cassman, 53, formerly directed NIGMS' Biophysics and Physiological Sciences Program. NIGMS, a component of the National Institutes of Health, funds research and training in the basic biomedical sciences. Its programs encompass the cellular and molecular basis of disease, genetics, pharmacology, biorelated chemistry, biophysics, physiologic

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Marvin Cassman has been appointed deputy director, National Institute of General Medical Sciences, by Health and Human Services Secretary Louis W. Sullivan. Cassman, 53, formerly directed NIGMS' Biophysics and Physiological Sciences Program.

NIGMS, a component of the National Institutes of Health, funds research and training in the basic biomedical sciences. Its programs encompass the cellular and molecular basis of disease, genetics, pharmacology, biorelated chemistry, biophysics, physiological sciences, and minority biomedical research and training. In his new position, Cassman will assist NIGMS Director Ruth Kirschstein in executing policies, coordinating activities, and allocating resources. He will also represent the institute in NIH forums and in dealings with other agencies, outside scientific organizations, and international scientific groups.

The new deputy director says one of his primary responsibilities will be dealing with policy issues, including budgetary concerns, such as "how to deal with the stress of a constricting funding base." It is "very painful," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies